Is the National Veterinary Care Ltd (ASX:NVL) share price a buy after its AGM?

Is the National Veterinary Care Ltd (ASX:NVL) share price a buy after holding its AGM?

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The National Veterinary Care Ltd (ASX: NVL) share price could be a buy after the company held its annual general meeting today.

The veterinary clinic operator gave a trading update along with providing a strategic review.

Trading update

The company has now settled 27 clinics since the start of FY19, which represents 41% growth of clinic numbers. This mainly relates to the New Zealand based Pet Doctors acquisition. An additional four clinics will be settled by the end of January 2019, which will bring the total up to 97.

National Veterinary Care said that it has achieved total portfolio organic revenue growth of 2.45% up to the end of October 2018.

Additionally, the veterinary clinic operator revealed that its Wellness Program has grown its membership by 13% since the start of FY19, with an NPS score of just over 75.

Strategy implementation

National Vet Care is working through the integration steps with the Pet Doctors business, which comprises 23 clinics and two training centres.

Management is implementing National Vet Care systems, recognising supplier synergies, reducing office support costs and reviewing the Pet Doctors operations.

Wages will be brought closer to National Vet Care levels and it will consider consolidating & merging clinics that are smaller and close together geographically.

FY19 guidance

Management re-iterated that based on the current initiatives and clinic numbers the full year guidance is for revenue growth of 40% more than last year and the underlying EBITDA margin will be 14.5% to 15%.

National Vet Care is going through a lot of growth and integration at the moment. The current market volatility is hurting small caps in-particular, its share price fell over 3% today.

I think it's trading attractively at 19x FY18's earnings. Until it reaches 150 clinics there could be a lot more profit growth to come.

A couple of people have suggested that if the Greencross Limited (ASX: GXL) takeover goes ahead then National Vet Care could acquire some of its standalone clinics. This could be very interesting for the company.

Motley Fool contributor Tristan Harrison owns shares of NATVETCARE FPO. The Motley Fool Australia owns shares of and has recommended Greencross Limited. The Motley Fool Australia owns shares of NATVETCARE FPO. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Three miners looking at a tablet.
Resources Shares

Own ASX mining shares? Experts say an upswing in commodity prices has begun

HSBC economists Paul Bloxham and Jamie Culling explain why global commodity prices are rising.

Read more »

A woman with a sad face looks to be receiving bad news on her phone as she holds it in her hands and looks down at it.
Share Fallers

Why Brambles, Lifestyle Communities, Northern Star, and Select Harvests shares are sinking

These shares are having a tough session. But why?

Read more »

A young woman sits at her desk in deep contemplation with her hand to her chin while seriously considering information she is reading on her laptop
Share Market News

Will the Reserve Bank wait for the US Fed to cut interest rates first?

Here's when AMP thinks interest rates will be cut in the US, Australia, New Zealand, Canada and the Eurozone.

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Share Gainers

Healthco Healthcare, Medadvisor, Ramsay Health Care, and Tamboran shares are rising

These shares are having a strong session. But why?

Read more »

drug capsule opening up to reveal dollar signs signifying rising asx share price
Share Gainers

If you invested $6,000 in Mesoblast shares a month ago you'd have $15,636 now!

Mesoblast shares have been on a tear this past month. But why?

Read more »

Gold bars on top of gold coins.
Gold

Is it too late to buy gold as an investment in 2024?

Can we still take advantage of gold at new record highs?

Read more »

A female broker in a red jacket whispers in the ear of a man who has a surprised look on his face as she explains which two ASX 200 shares should do well in today's volatile climate
Mergers & Acquisitions

Wesfarmers shares baulk on fresh acquisition gossip

A healthcare company gone nowhere in a decade might be on Wesfarmers' radar.

Read more »

Arrows pointing upwards with a man pointing his finger at one.
52-Week Highs

7 ASX All Ords shares smashing new 52-week highs on Tuesday

Do you own any of these stocks at new highs today?

Read more »